Chemotherapy by slowing glucosphingolipid synthesis.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Biochemical Pharmacology

• Publication date

  1999-03-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0006-2952(98)00274-3PMID 10037442
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Induction of ganglioside biosynthesis and neurite outgrowth of primary cultured neurons by L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol.

  2002cited by this paper
• Glucosylceramide: a marker for multiple-drug resistant cancers.

  1998cited by this paper
• Synthesis, Shedding, and Intercellular Transfer of Human Medulloblastoma Gangliosides: Abrogation by a New Inhibitor of Glucosylceramide Synthase

  1998cited by this paper
• Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin.

  1997cited by this paper
• Shedding of gangliosides by human medulloblastoma cells.

  1997cited by this paper
• Nanomolar concentrations of gangliosides stimulate primary humoral response

  1997cited by this paper
• Cellular cancer vaccine induces delayed-type hypersensitivity reaction and augments antibody response to tumor-associated carbohydrate antigens (sialyl Lea, sialyl Lex, GD3 and GM2) better than soluble lysate cancer vaccine

  1997cited by this paper
• The Growth Arresting Effect of Human Immunoglobulin for Intravenous Use Is Mediated by Antibodies Recognizing Membrane Glycolipids

  1997cited by this paper
• Elevated levels of M-CSF, sCD14 and IL8 in type 1 Gaucher disease.

  1997cited by this paper
• Agents that Reverse Multidrug Resistance, Tamoxifen, Verapamil, and Cyclosporin A, Block Glycosphingolipid Metabolism by Inhibiting Ceramide Glycosylation in Human Cancer Cells*

  1997cited by this paper
• MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine.

  1996cited by this paper
• Treatment of Gaucher disease with an enzyme inhibitor

  1996cited by this paper
• Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.

  1996cited by this paper
• Reversal of adriamycin resistance with chimeric anti‐ganglioside GM2 antibody

  1996cited by this paper
• Glucosylceramides stimulate murine epidermal hyperproliferation.

  1995cited by this paper
• Abnormalities of glycosphingolipid, sulfatide, and ceramide in the polycystic (cpk/cpk) mouse.

  1994cited by this paper
• Epithelial glucosphingolipid expression as a determinant of bacterial adherence and cytokine production

  1994cited by this paper
• Modulation of human myelopoiesis by human gangliosides.

  1994cited by this paper
• A role for glycosphingolipid accumulation in the renal hypertrophy of streptozotocin-induced diabetes mellitus.

  1993cited by this paper
• Gangliosides inhibit T-lymphocyte proliferation by preventing the interaction of interleukin-2 with its cell surface receptors.

  1993cited by this paper
• Control of kidney size by sex hormones: possible involvement of glucosylceramide.

  1992cited by this paper
• Lactosylceramide stimulates aortic smooth muscle cell proliferation.

  1991cited by this paper
• Modulation of renal epithelial cell growth by glucosylceramide. Association with protein kinase C, sphingosine, and diacylglycerol.

  1991cited by this paper
• Metabolism of D-[3H]threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol, an inhibitor of glucosylceramide synthesis, and the synergistic action of an inhibitor of microsomal monooxygenase.

  1991cited by this paper
• Inhibition of experimental metastasis of murine Lewis lung carcinoma by an inhibitor of glucosylceramide synthase and its possible mechanism of action.

  1990cited by this paper
• Stimulation of liver growth and DNA synthesis by glucosylceramide

  1988cited by this paper
• Changes in plasma gangliosides in relation to tumor growth and their tumor‐enhancing effect

  1988cited by this paper
• Glucosphingolipids as sites of action in the chemotherapy of cancer.

  1988cited by this paper
• Antitumor activity via inhibition of glycosphingolipid biosynthesis.

  1987cited by this paper
• Enzymic effects of beta-glucosidase destruction in mice. Changes in glucuronidase levels.

  1979cited by this paper

• Inhibition of glycosphingolipid synthesis with eliglustat in combination with immune checkpoint inhibitors in advanced cancers: preclinical evidence and phase I clinical trial

  2024cites this paper
• The Uridine diphosphate (UDP)-glycosyltransferases (UGTs) superfamily: the role in tumor cell metabolism

  2023cites this paper
• Ceramide glycosylation and related enzymes in cancer signaling and therapy.

  2021cites this paper
• Playing hide and seek: Tumor cells in control of MHC class I antigen presentation.

  2021cites this paper
• Delivery of long chain C16 and C24 ceramide in HeLa cells using oxidized graphene nanoribbons.

  2020cites this paper
• The Role of Glycosphingolipids in Immune Cell Functions

  2019cites this paper
• Gaucher disease and chronic myeloid leukemia: first reported patient receiving enzyme replacement and tyrosine kinase inhibitor therapies simultaneously

  2018cites this paper
• Nanoparticle-based drug delivery in cancer: the role of cell membrane structures.

  2016cites this paper
• Pancreatic Cancer and Sphingolipids

  2015cites this paper
• Biochemical Roles of Eukaryotic Cell Surface Macromolecules

  2015cites this paper
• Tamoxifen regulation of sphingolipid metabolism--Therapeutic implications.

  2015cites this paper
• O papel de gangliosídeos específicos como moduladores da liberação de mediadores de mastócitos

  2015cites this paper
• Regulations of glycolipid: XI. glycosyltransferase (GSL: GLTs) genes involved in SA-LeX and related GSLs biosynthesis in carcinoma cells by Biosimilar apoptotic agents: potential anticancer drugs.

  2015cites this paper
• Neuroepithelioma Cells RTN-1C Regulate Chemotherapeutic-induced Apoptosis in Glucosylceramide Synthase and Its Functional Interaction with

  2013cites this paper
• Gaucher disease and malignancy: a model for cancer pathogenesis in an inborn error of metabolism.

  2013cites this paper
• Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer

  2012cites this paper
• Phenotype diversity in type 1 Gaucher disease: discovering the genetic basis of Gaucher disease/hematologic malignancy phenotype by individual genome analysis.

  2012cites this paper
• Apoptosis of breast cancer cells: modulation of genes for glycoconjugate biosynthesis and targeted drug delivery.

  2012cites this paper
• Glycosphingolipids and kidney disease.

  2011cites this paper
• Apoptotic Sphingolipid Ceramide in Cancer Therapy

  2011cites this paper
• Nous ciclitols com a inhibidors de la glucocerebrosidasa. Aplicació al disseny de xaperones farmacològiques per al tractament de la malaltia de Gaucher

  2011cites this paper
• Sphingolipids and metabolic disease

  2011cites this paper
• GCS induces multidrug resistance by regulating apoptosis-related genes in K562/AO2 cell line

  2010cites this paper
• Post-translational and transcriptional regulation of glycolipid glycosyltransferase genes in apoptotic breast carcinoma cells: VII. Studied by DNA-microarray after treatment with l-PPMP

  2009cites this paper
• Glucosylceramide synthase inhibitors sensitise CLL cells to cytotoxic agents without reversing P-gp functional activity.

  2009cites this paper
• Highly Regioselective Oxirane Ring‐Opening of a Versatile Epoxypyrrolidine Precursor of New Imino‐Sugar‐Based Sphingolipid Mimics

  2009cites this paper
• The alpha-galactosyl derivatives of ganglioside GD(1b) are essential for the organization of lipid rafts in RBL-2H3 mast cells.

  2008cites this paper
• C-Alkyl 5-membered ring imino sugars as new potent cytotoxic glucosylceramide synthase inhibitors.

  2006cites this paper
• Sphingolipids, cholesterol, and HIV-1: A paradigm in viral fusion

  2006cites this paper
• Glycosphingolipids and drug resistance.

  2006cites this paper
• Cancer Cells to Anticancer Drugs P-Glycoprotein and Resensitizes Multidrug-Resistant Breast Glucosylceramide Synthase Blockade Down-Regulates

  2005cites this paper
• Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs.

  2005cites this paper
• Inhibition of Glucosylceramide Synthase Does Not Reverse Drug Resistance in Cancer Cells*

  2004cites this paper
• Models of Krabbe Disease

  2004cites this paper
• Phosphatidylcholine metabolism is altered in a monocyte-derived macrophage model of Gaucher disease but not in lymphocytes.

  2004cites this paper
• Apoptosis of human carcinoma cells in the presence of inhibitors of glycosphingolipid biosynthesis: I. Treatment of Colo-205 and SKBR3 cells with isomers of PDMP and PPMP

  2004cites this paper
• Modulators of ceramide metabolism sensitize colorectal cancer cells to chemotherapy: A novel treatment strategy

  2003cites this paper
• Apoptosis of human breast carcinoma cells in the presence of disialosyl gangliosides: II. Treatment of SKBR3 cells with GD3 and GD1b gangliosides

  2003cites this paper
• Killing tumours by ceramide-induced apoptosis: a critique of available drugs.

  2003cites this paper
• Are animal models useful for understanding the pathophysiology of lysosomal storage disease?

  2003cites this paper
• Designing anticancer drugs via the achilles heel: ceramide, allylic ketones, and mitochondria.

  2003cites this paper
• RNA interference: analyzing the function of glycoproteins and glycosylating proteins in mammalian cells.

  2003cites this paper
• Glucosylceramide synthase and its functional interaction with RTN-1C regulate chemotherapeutic-induced apoptosis in neuroepithelioma cells.

  2003cites this paper
• Cancer progression in the kidney and prostate: vital roles of sphingolipids in chemotherapy.

  2002cites this paper
• Inhibition of glycolipid shedding rescues recognition of a CD1+ T cell lymphoma by natural killer T (NKT) cells

  2002cites this paper
• Substrate-Reduction Therapy Enhances the Benefits of Bone Marrow Transplantation in Young Mice with Globoid Cell Leukodystrophy

  2002cites this paper
• Asialo-GM1 and asialo-GM2 are putative adhesion molecules for Moraxella catarrhalis

  2002cites this paper
• The Development of Aggressive Cancer: A Possible Role for Sphingolipids

  2002cites this paper
• Phosphatidylcholine synthesis is elevated in neuronal models of Gaucher disease due to direct activation of CTP:phosphocholine cytidylyltransferase by glucosylceramide

  2002cites this paper
• Plasma glucosylceramide deficiency as potential risk factor for venous thrombosis and modulator of anticoagulant protein C pathway.

  2001cites this paper
• Targeting ceramide metabolism--a strategy for overcoming drug resistance.

  2001cites this paper
• Metabolic liver disease

  2001cites this paper
• Identification of Active Site Residues in Glucosylceramide Synthase

  2001cites this paper
• Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis.

  2001cites this paper
• Killing cancer cells by poly-drug elevation of ceramide levels: a hypothesis whose time has come?

  2001cites this paper
• Ceramide glycosylation potentiates cellular multidrug resistance

  2001cites this paper
• N -butyldeoxynojirimycin reduces growth and ganglioside content of experimental mouse brain tumours

  2001cites this paper
• Twitcher mice with only a single active galactosylceramide synthase gene exhibit clearly detectable but therapeutically minor phenotypic improvements

  2000cites this paper
• Paradoxical influence of acid beta-galactosidase gene dosage on phenotype of the twitcher mouse (genetic galactosylceramidase deficiency).

  2000cites this paper
• Physiology and pathophysiology of sphingolipid metabolism and signaling.

  2000cites this paper
• Sphingolipids: Mechanism-Based Inhibitors of Carcinogenesis Produced by Animals, Plants, and Other Organisms

  2000cites this paper
• Treating glucosphingolipid disorders by chemotherapy: Use of approved drugs and over-the-counter remedies

  2000cites this paper
• Cytotoxicity of L-cycloserine against human neuroblastoma and medulloblastoma cells is associated with the suppression of ganglioside expression.

  1999cites this paper
• Modification of ceramide metabolism increases cancer cell sensitivity to cytotoxics.

  1999cites this paper
• Ceramide Glycanase Activities in Human Cancer Cells

  1999cites this paper